- Home
- ACP vs THW Comparison
ACP vs THW Comparison
Compare ACP & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | ACP | THW |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 637.4M | 540.1M |
| IPO Year | 2010 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ACP | THW |
|---|---|---|
| Price | $5.14 | $13.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 566.6K | 144.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 17.79% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.99 | $11.18 |
| 52 Week High | $5.99 | $14.10 |
Technical Indicators
Market Signals| Indicator | ACP | THW |
|---|---|---|
| Relative Strength Index (RSI) | 51.42 | 68.10 |
| Support Level | $5.13 | $12.33 |
| Resistance Level | $5.32 | N/A |
| Average True Range (ATR) | 0.05 | 0.21 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 90.63 | 85.71 |
Price Performance
Historical ComparisonAbout ACP abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income with a secondary objective of capital appreciation. It predominantly invests in debt and loan instruments of issues that operate in a variety of industries and geographic regions.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.